Developing new vaccines to prevent chlamydia infections in men
Official title: Investigation of novel chlamydia vaccines in male infection models and sexual transmission challenges
Funded at University of New Mexico Health Scis Ctr · NIH-11000254 · Data updated 2026-11-12
This study is testing new vaccines to help protect against Chlamydia, a common sexually transmitted infection, especially focusing on how it affects men and the risk of spreading it, using a special method that could boost the immune response.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of New Mexico Health Scis Ctr NIH-funded |
| Lab location | 1 site (Albuquerque, United States) |
| Project start | September 1, 2023 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $38,374 |
| NIH project number | 5F31AI179064-02 |
| Project ID | NIH-11000254 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include men who are at risk of chlamydia infections, particularly those with a history of sexually transmitted infections.
✕Less likely to help
Patients who are not sexually active or those who have already been effectively treated for chlamydia may not benefit from this research.
What this research studies
This research focuses on creating novel vaccines to combat Chlamydia trachomatis, the bacteria responsible for the most common bacterial sexually transmitted infection. The study aims to address the gap in understanding male infections and their role in transmission, particularly in the context of anorectal infections. By using innovative bacteriophage virus-like particles as a vaccine platform, the research seeks to enhance immune responses and reduce the risk of reinfection. The approach involves testing these vaccines in male infection models to evaluate their effectiveness in preventing transmission.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines that prevent chlamydia infections, reducing the incidence of severe health complications associated with the disease.
How similar studies have gone: While there has been significant research on chlamydia treatment, the development of vaccines using this specific approach is relatively novel and has not been extensively tested.
Where this research is happening
-
University of New Mexico Health Scis Ctr
Albuquerque, United States Active
Researchers
- Principal investigator: Jamus, Andzoa — University of New Mexico Health Scis Ctr
- Study coordinator: Jamus, Andzoa
Related research
Other NIH-funded projects on the same topics.
-
Investigating how a specific signaling molecule affects brain blood vessel health in dementia.
This study is looking at how a substance called sphingosine 1 phosphate (S1P) might help protect the blood-brain barrier and improve brain health for people with Cerebral Small Vessel Disease, which can lead to dementia, and it hopes to find new ways to slow down or prevent this condition.
-
Administrative Core for a Cancer Research Program
This NIH grant funds an Administrative Core to manage a large cancer research program and ensure compliance, coordination, and data resources to support studies on cancer causes and patient populations.
-
Administrative Core for a cancer research program
A central hub at a major medical center helps coordinate cancer research, data resources, and compliance to accelerate progress for people affected by cancer.
-
Engagement Optimization for AI/AN Cancer Genomics and Care
A patient-friendly project aims to use AI tools to better understand cancer genetics in American Indian and Alaska Native communities and use that knowledge to improve screening, prevention, and treatment.
-
GenomeCharacterization for AI/AN Cancer Health
A large NIH project aims to map the cancer genomes of American Indian and Alaska Native people to uncover unique mutations and patterns that could improve cancer screening, prevention, and treatment for AI/AN communities.
-
Engaging AI/AN Communities in Cancer Genomics for Better Screening and Care
A community-engaged research effort to understand cancer genetics in American Indian and Alaska Native people with the goal of improving screening, prevention, and treatment.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.